← SynDRA
BRENSOCATIB
SynDRA canonical compound SYN0038621 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | CTSC |
|---|
| Mechanism of action | dipeptidyl peptidase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- CTSC INHIBITOR
- Dipeptidyl peptidase I inhibitor
- dipeptidyl peptidase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CTSB
- CTSD
- CTSE
- CTSG
- CTSH
- CTSK
- CTSL
- CTSS
- CTSZ
- ELANE
- KCNH2
- PRTN3
Cross-references
Synonyms
- BRINSUPRI
- Brinsupri
- AZD-7986
- AZD7986
- INS-1007
- INS1007
- INS 1007
- RefChem:121325
- Brensocatib [USAN]
- UNII-25CG88L0BB
- WHO 11097
- AEXFXNFMSAAELR-RXVVDRJESA-N
- BRENSOCATIB [INN]
- Brensocatib (USAN/INN)
- BRENSOCATIB [WHO-DD]
- GTPL9412
- orb1296252
- SCHEMBL16932317
- SCHEMBL29363739
- C23H24N4O4
- GLXC-21270
- EX-A1866
- AZD7986;INS 1007
- BDBM50195235
- AC-36222
- AS-84225
- BB177302
- DA-71203
- HY-101056
- CS-0020766
- D12120
- D84088
- Brensocatib monohydrate
- PFW1O9NG45
- Brinsupri (TN)
- D12746
- Brensocatib hydrate (JAN)
- SB18722
Look up BRENSOCATIB in the interactive SynDRA portal →